<?xml version="1.0" encoding="UTF-8"?>
<p content-type="disclosure">J. Maple-Grødem, I. Dalen, and O.-B. Tysnes report no disclosures relevant to the manuscript. A. Macleod reports fellowship funding from the Scottish Chief Scientist Office (PCL/17/10) and grant funding from the Academy of Medical Sciences and NHS Grampian Endowments. L. Forsgren reports no disclosures relevant to the manuscript. C. Counsell reports NHS Grampian Endowments and RS Macdonald Trust. G. Alves reports Norwegian Research Council grant 287842, principal investigator, 2019–2022 and support from University of Stavanger, Norwegian Parkinson Research Foundation, and Reberg's Legacy. Go to 
 <ext-link ext-link-type="uri" xlink:href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000011411" xmlns:xlink="http://www.w3.org/1999/xlink">Neurology.org/N</ext-link> for full disclosures.
</p>
